A246710 Stock Overview
Engages in the research and development of medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
T&R Biofab Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,520.00 |
| 52 Week High | ₩13,890.00 |
| 52 Week Low | ₩5,190.00 |
| Beta | 0.77 |
| 11 Month Change | 0.93% |
| 3 Month Change | -16.62% |
| 1 Year Change | -46.16% |
| 33 Year Change | -83.68% |
| 5 Year Change | 32.93% |
| Change since IPO | 4.32% |
Recent News & Updates
Recent updates
Is T&R Biofab (KOSDAQ:246710) Using Debt Sensibly?
Feb 26
Do Insiders Own Lots Of Shares In T&R Biofab Co., Ltd. (KOSDAQ:246710)?
Mar 09Can You Imagine How T&R Biofab's (KOSDAQ:246710) Shareholders Feel About The 65% Share Price Increase?
Jan 12
Do Institutions Own T&R Biofab Co., Ltd. (KOSDAQ:246710) Shares?
Nov 18Shareholder Returns
| A246710 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 10.9% | 12.8% | 7.9% |
| 1Y | -46.2% | 17.7% | -0.5% |
Return vs Industry: A246710 underperformed the KR Medical Equipment industry which returned 17.7% over the past year.
Return vs Market: A246710 underperformed the KR Market which returned -0.5% over the past year.
Price Volatility
| A246710 volatility | |
|---|---|
| A246710 Average Weekly Movement | 7.5% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A246710's share price has been volatile over the past 3 months.
Volatility Over Time: A246710's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Wonsoo Yun | www.tnrbiofab.com |
T&R Biofab Co., Ltd. engages in the research and development of medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. It offers craniomaxillofacial meshes, dental meshes, and patient specific implants; and bioinks for 3D bioprinting and cell culture, stem cell research and delivery, and coating of scaffold and cultural dishes. The company was founded in 2013 and is based in Siheung-si, South Korea.
T&R Biofab Co., Ltd. Fundamentals Summary
| A246710 fundamental statistics | |
|---|---|
| Market cap | ₩140.49b |
| Earnings (TTM) | -₩17.49b |
| Revenue (TTM) | ₩4.79b |
29.3x
P/S Ratio-8.0x
P/E RatioIs A246710 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A246710 income statement (TTM) | |
|---|---|
| Revenue | ₩4.79b |
| Cost of Revenue | ₩3.63b |
| Gross Profit | ₩1.16b |
| Other Expenses | ₩18.65b |
| Earnings | -₩17.49b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -811.60 |
| Gross Margin | 24.22% |
| Net Profit Margin | -364.71% |
| Debt/Equity Ratio | 150.4% |
How did A246710 perform over the long term?
See historical performance and comparison